Delivery Order SPE2DB24D2100-SPE2DB25FBEUG
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,318.60 to AmerisourceBergen Drug Corp for the supply of Methylphenidate ER 54 mg tablets (100 count units). The contract is a firm fixed price, non-set-aside delivery order with an ultimate completion date of July 31, 2025, awarded on July 30, 2025. AmerisourceBergen Drug Corp will perform this work from its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,017.91 to AmerisourceBergen Drug Corp for the supply of Methylphenidate ER 36 mg tablets in quantities of 100 units. This is a firm fixed price, non-set-aside competitive award with a performance location in Conshohocken, Pennsylvania, and an ultimate completion date of July 30, 2025. The delivery order was issued on July 29, 2025, under AmerisourceBergen's existing contract vehicle with DLA. This delivery order is issued...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on June 24, 2025, for the supply of Methylphenidate ER (extended-release) tablets at 54mg dosage. This firm fixed-price delivery order, valued at $6,673.17, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical designated SPE2DX, which carries a $999,999,999.00 ceiling value through December 2026. The...
- The Defense Logistics Agency has awarded a delivery order valued at $1,180.54 to AmerisourceBergen Drug Corp for the supply of Methylphenidate ER 36 mg tablets (100 count). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of July 11, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office location. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $1,176.88 to AmerisourceBergen Drug Corp for the supply of Methylphenidate ER 27 mg tablets (100-count) on May 6, 2025, with completion scheduled for May 7, 2025. This firm fixed-price delivery order represents a competitively awarded, non-set-aside contract with performance based in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a delivery order valued at $1,690.77 to AmerisourceBergen Drug Corp for the supply of Methylphenidate ER 54 mg tablets (100-count bottles) on July 30, 2025, with completion scheduled for July 31, 2025. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation, to be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The order falls under the company's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $3,511.72 to AmerisourceBergen Drug Corp for the supply of Methylphenidate ER 54 mg tablets (100 count) with completion scheduled for June 3, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is performed from the awardee's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,649.02 to AmerisourceBergen Drug Corp for Methylphenidate ER 54 mg tablets (100-count units) on July 24, 2025, with completion targeted for July 25, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $1,448.52 to supply Methylphenidate ER 36 mg tablets (100-count units) with an ultimate completion date of August 19, 2025. The contract is classified as a non-set-aside, competitively awarded delivery order with firm fixed pricing. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, is performing the work at its corporate office location. This...
- The Defense Logistics Agency awarded a delivery order valued at $2,365.50 to AmerisourceBergen Drug Corp for Methylphenidate ER 54 mg tablets (100 count) on October 27, 2025, with an ultimate completion date of October 28, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania location. The delivery order represents a child contract under AmerisourceBergen's broader pharmaceutical supply...
- SPE2DB24D2100Indefinite Delivery Contract
- SPE2DB24D2100-SPE2DB25FBEUGDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,067.06 to AmerisourceBergen Drug Corp for the supply of Methylphenidate ER 54 mg tablets (100-count bottles). The contract employs firm fixed-price terms with an ultimate completion date of June 18, 2025, and was awarded on June 17, 2025, without set-aside designation. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (designated SPE2DX), a $999.99 billion comprehensive pharmaceutical supply vehicle running through December 2026. The place of performance is AmerisourceBergen's distribution center located in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical procurement vendor that supplies a comprehensive range of medications and medical supplies to support military and veteran healthcare systems. The company's federal contract portfolio demonstrates consistent competitively-awarded agreements with DLA and the Defense Health Agency, encompassing brand-name and generic pharmaceuticals, vaccines, and specialized medical devices across multiple therapeutic categories. This delivery order for methylphenidate reflects the company's ongoing role in meeting federal medical supply requirements through its prime vendor relationship with DLA, enabling efficient pharmaceutical support for Department of Defense healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 6/17/25 |